<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00351429</url>
  </required_header>
  <id_info>
    <org_study_id>1PN1010510</org_study_id>
    <nct_id>NCT00351429</nct_id>
  </id_info>
  <brief_title>Study of PGA Suture in Ophthalmology</brief_title>
  <official_title>Evaluating the Safety and Efficacy of Polyglycolic Acid Suture in Ophthalmic Surgical Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aurolab</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aurolab</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and efficacy of polyglycolic acid suture in ophthalmic surgical&#xD;
      procedures&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The sutures are classified into non-absorbable and absorbable sutures. Violet braided&#xD;
      polyglycolic acid suture is the synthetic absorbable suture used in wound closure in&#xD;
      ophthalmology, cardiology, neurology and plastic &amp; reconstructive surgeries. In&#xD;
      ophthalmology, PGA sutures are used in Trabeculectomy (Glaucoma), Orbit and Oculoplasty, Lid&#xD;
      and Socket Reconstruction, Squint, ptosis and retinal detachment surgeries.&#xD;
&#xD;
      Glaucoma patients who met the inclusion criteria were recruited for this study. Uniform&#xD;
      surgery and suturing technique was performed in all patients (Trabeculectomy with IOL&#xD;
      implantation). Surgeon assessed suture characteristics during surgery and wound integrity at&#xD;
      the end of surgery.&#xD;
&#xD;
      Patients were followed up during 1 day, 1 month and 3 months post operatively. Visual acuity,&#xD;
      Intraocular Pressure (IOP), suture characteristics, wound integrity, inflammation and&#xD;
      conjunctival status were examined during each follow up visit.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2005</start_date>
  <completion_date type="Actual">May 2006</completion_date>
  <primary_completion_date type="Actual">May 2006</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Suture characteristics</measure>
    <time_frame>1 month, 3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bleb characteristics</measure>
    <time_frame>1 month, 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conjunctival status</measure>
    <time_frame>1 month, 3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Polyglycolic acid suture</intervention_name>
    <description>PGA suture used in Trabeculectomy surgery</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Aurocryl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing Trabeculectomy with IOL implantation&#xD;
&#xD;
          -  Current residence within 60 kms of madurai&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Life threatening illness&#xD;
&#xD;
          -  Immunosuppressive disorders&#xD;
&#xD;
          -  Chronic infection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ramaswamy Krishnadas, DO, Dip NB</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aravind Eye Hospital, Madurai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aravind Eye Hospital</name>
      <address>
        <city>Madurai</city>
        <state>Tamil Nadu</state>
        <zip>625 020</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <study_first_submitted>July 11, 2006</study_first_submitted>
  <study_first_submitted_qc>July 11, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2006</study_first_posted>
  <last_update_submitted>February 10, 2009</last_update_submitted>
  <last_update_submitted_qc>February 10, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 11, 2009</last_update_posted>
  <responsible_party>
    <name_title>A. Heber</name_title>
    <organization>Aurolab</organization>
  </responsible_party>
  <keyword>Glaucoma</keyword>
  <keyword>Trabeculectomy</keyword>
  <keyword>Sutures</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

